COPD Alliance Aims for Better Recognition and Care of COPD

Web Exclusives
Wayne Kuznar

Launched at Chest 2010, a new COPD Alliance is focusing on a national education campaign to raise the awareness of primary care physicians of chronic obstructive pulmonary disease (COPD) and bring about significant change in the diagnosis and treatment of this progressing, chronic disease.

The COPD Alliance is composed of several national societies—the American College of Chest Physicians, the American Academy of Nurse Practitioners, the American Academy of Family Physicians, the American College of Osteopathic Family Physicians, and the American College of Osteopathic Internists (representing about 200,000 primary care and specialty physicians).

The need for the campaign is obvious considering that only about 50% of the 24 million Americans with COPD have been diagnosed. Accord ing to Brian W. Carlin, MD, Chair of the COPD Alliance, the total cost of COPD in 2010 is expected to be $49.9 billion, which includes $29.5 billion in direct healthcare expenditures and $20.4 billion in indirect costs.

The alliance will ask primary care physicians to integrate the routine use of validated screening measures for patients at risk for the development of COPD, to use spirometry to confirm the diagnosis, and to use evidence-based therapy in the management of COPD patients, Dr Carlin said.

The COPD Alliance has launched a website (www.COPD.org) that grants access to free COPD tools; it will serve as an electronic toolkit to support the efforts of healthcare providers, patients, and caregivers. Outreach and promotional strategies will be used to reach members.

In 2011, each society in the alliance will develop and deliver educational strategies specifically tailored to its membership. Clinicians in training will also be targeted, Dr Carlin said, because few training programs offer comprehensive training in COPD management for residents or fellows.

As part of its strategy, the alliance will keep current tools available, such as the COPD Population Screener, the Tobacco Dependence Treatment Toolkit, the GOLD (Global Initiative for Chronic Obstructive Lung Disease) re commendations for diagnosing and treating COPD, and case-based COPD video vignettes

Related Items
The Pediatric MATCH Study: Actionable Targets Found in 25% of Young Patients with Cancer
Wayne Kuznar
August 2019, Vol 12, Special Issue: Payers’ Perspectives In Oncology: ASCO 2019 Highlights published on August 16, 2019 in Pediatric Cancer
Autologous Mesothelin-Targeted T-Cells Induce Responses in Pleural Solid Tumors
Wayne Kuznar
August 2019, Vol 12, Special Issue: Payers’ Perspectives In Oncology: ASCO 2019 Highlights published on August 16, 2019 in Emerging Therapies
Selective, Small-Molecule DRD2 Antagonist Induces Tumor Regression in Recurrent High-Grade Glioma
Wayne Kuznar
August 2019, Vol 12, Special Issue: Payers’ Perspectives In Oncology: ASCO 2019 Highlights published on August 16, 2019 in Emerging Therapies
Expanding Treatment Options for Patients with Advanced Cholangiocarcinoma
Wayne Kuznar
August 2019, Vol 12, Special Issue: Payers’ Perspectives In Oncology: ASCO 2019 Highlights published on August 16, 2019 in Cholangiocarcinoma
Larotrectinib Has Wide-Ranging Efficacy in Advanced Solid Tumors with NTRK Gene Fusion
Wayne Kuznar
August 2019, Vol 12, Special Issue: Payers’ Perspectives In Oncology: ASCO 2019 Highlights published on August 16, 2019 in Biomarkers
Last modified: February 14, 2019
  •  Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME